HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Jean Philippe European fragrance sales offset Cutex losses; Allou net income increases.

This article was originally published in The Rose Sheet

Executive Summary

JEAN PHILIPPE INTER PARFUMS 50% FRAGRANCE SALES SECOND QUARTER GROWTH almost completely offsets the revenue declines resulting from the loss of the Cutex brand license, Jean Philippe reported Aug. 12. Fragrance sales from the French Inter Parfums subsidiary have exceeded Jean Philippe's expectations, the firm said, noting that the Burberrys of London fragrances, and specifically the Week end fragrance duo and body and hair care products, are driving sales. Week end was introduced under the Burberrys umbrella in Europe in March, Jean Philippe said

You may also be interested in...



S.T. Dupont Signature Fragrance Duo Set To Make Its Mark

S.T. Dupont will introduce Signature scents for men and women in April. The Paris-based firm, which is best known for its luxury pens, lighters and accessories, also markets a pair of S.T. Dupont scents.

Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Gel

Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004509

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel